CENTRAL GARDEN & PET CO (CENT): Results of Operations and Financial Condition
CENTRAL GARDEN & PET CO (CENT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CENTRAL GARDEN & PET ANNOUNCES Q3 FISCAL 2026 FINANCIAL RESULTS Reports fiscal 2026 Q3 net sales decline of 8%, with organic sales growth of 2% Delivers fiscal 2026 Q3 GAAP diluted EPS of $1.45 versus $1.52 in the prior year, and non-GAAP EPS of $1.54 versus $1.56 Ra
How this was made
The 30-second read
Why it matters
Traders can update models using the new Q3 datapoints (GAAP and non-GAAP EPS, margins, segment performance) and the raised FY non-GAAP EPS outlook, while also incorporating deal terms (consideration, ownership %, expected close window) into risk and valuation frameworks.
Market read
The filing combines a guidance raise with a definitive acquisition, making it a direct catalyst for earnings expectations and deal-related risk premia.
What to watch
The guidance outlook explicitly assumes stability in commodities and tariffs; any deviation could pressure the raised non-GAAP EPS target, and integration execution risk remains for TRIXIE.
Central Garden & Pet Announces Q3 Fiscal 2026 Financial Results: net sales declined 8%, organic sales grew 2%, and fiscal 2026 non-GAAP diluted EPS outlook was raised to $2.85 or better.
Organic sales growth, broad margin expansion, improved operating cash flow, and a higher fiscal 2026 non-GAAP diluted EPS outlook offset the reported net-sales decline and lower GAAP and non-GAAP earnings versus Q3 FY 2025.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Net salesGAAP | $882 million | – | decrease of 8% |
| Organic net salesother | $862 million | – | increase of 2% |
| Gross profitGAAP | $317 million | – | decrease of 5% |
| Gross marginGAAP | 35.9% | – | expanding by 130 basis points |
| SG&AGAAP | $191 million | – | decrease of 3% |
| SG&Anon-GAAP | $182 million | – | decrease of 6% |
| Operating incomeGAAP | $126 million | – | decrease of 7% |
| Operating marginGAAP | 14.3% | – | expanding by 20 basis points |
| Operating incomenon-GAAP | $136 million | – | decrease of only 2% |
| Operating marginnon-GAAP | 15.4% | – | expanding by 90 basis points |
| Other incomeGAAP | $2 million | – | slightly above the prior year |
| Net interest expenseGAAP | $8 million | – | lower than a year ago |
| Net incomeGAAP | $90 million | – | decrease of 5% |
| Diluted EPSGAAP | $1.45 per diluted share | – | decrease of $0.07 |
| Net incomenon-GAAP | $96 million | – | decrease of 2% |
| Diluted EPSnon-GAAP | $1.54 per diluted share | – | decrease of $0.02 |
| Adjusted EBITDAnon-GAAP | $162 million | – | decrease of $5 million |
| Adjusted EBITDA marginnon-GAAP | 18.3% | – | expanding by 100 basis points |
| Pet segment operating incomeGAAP | $67 million | – | decrease of 12% |
| Pet segment operating marginGAAP | 16.7% | – | up 120 basis points |
| Pet segment operating incomenon-GAAP | $76 million | – | decrease of 2% |
| Pet segment operating marginnon-GAAP | 19.0% | – | up 320 basis points |
| Pet segment adjusted EBITDAnon-GAAP | $86 million | – | decrease of $2 million |
| Pet segment adjusted EBITDA marginnon-GAAP | 21.4% | – | up 350 basis points |
| Garden segment operating incomeGAAP | $90 million | – | increase of 9% |
| Garden segment operating marginGAAP | 18.7% | – | expanding by 100 basis points |
| Garden segment operating incomenon-GAAP | $91 million | – | increase of 7% |
| Garden segment operating marginnon-GAAP | 18.9% | – | up 70 basis points |
| Garden segment adjusted EBITDAnon-GAAP | $101 million | – | increase of $5 million |
| Garden segment adjusted EBITDA marginnon-GAAP | 20.9% | – | up 50 basis points |
| Cash provided by operationsGAAP | $327 million | – | – |
| Cash and cash equivalentsGAAP | $997 million | – | – |
| Total debtGAAP | $1.2 billion | – | consistent with the prior year period |
| Gross leverageother | 2.8x | – | – |
| Net leverageother | 0.5x | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Petreflecting the exit of the pet distribution business | $400 million | – | decrease of 19% |
| Pet organic net salesOrganic net sales in the Pet segment increased. | $380 million | – | increase of 2% |
| GardenThe increase was primarily driven by Wild Bird, Fertilizer and Controls, and Grass Seeds. | $482 million | – | increase of 3% |
Fiscal 2026 outlook
- NoteNon-GAAP diluted EPS: $2.85 or better
- NoteCapital expenditures: approximately $50 million
Capital returns
- As of June 27, 2026, $128 million remained available for future stock repurchases.
What drove it
- Organic net sales grew 2% after taking into account the exit of the pet distribution business at the beginning of the quarter.
- Gross-margin expansion was attributed primarily to the exit of the pet distribution business earlier in the year.
- Garden sales growth was primarily driven by Wild Bird, Fertilizer and Controls, and Grass Seeds.
- Fiscal 2026 non-GAAP diluted EPS guidance was raised, driven by continued margin discipline, ongoing investment in growth initiatives, and portfolio optimization.
- Central entered into a definitive agreement after quarter-end to acquire an 80% interest in TRIXIE Heimtierbedarf GmbH & Co. KG.
Concerns
- Reported net sales decreased 8%, while Pet segment net sales decreased 19% reflecting the exit of the pet distribution business.
- GAAP net income decreased 5%, GAAP diluted EPS decreased $0.07, and adjusted EBITDA decreased $5 million.
- The outlook incorporates assumptions regarding a competitive and promotional retail environment, a value-oriented consumer, existing tariffs, and inflation in select commodities.
- The outlook excludes potential impacts from further acquisitions, divestitures, or restructuring activities during the remainder of fiscal 2026, including projects under the Cost and Simplicity agenda, as well as further tariff refunds.
What to watch
- Completion of the TRIXIE transaction, which is expected to close in the first half of fiscal 2027.
- The transaction consideration is €340 million in cash at closing plus up to €60 million in additional earn-out payments, for total consideration of up to €400 million.
- Central stated that the transaction will give it a differentiated presence with approximately 10% of net sales generated outside of the United States.
- The balance of the garden season and the company's assumptions on consumer demand, retail promotion, tariffs, inflation, and key commodities.
- Fiscal 2026 capital expenditures projected to be approximately $50 million, focused on maintenance, productivity initiatives, and targeted growth investments across both segments.
Balance sheet and cash flow
- Cash provided by operations was $327 million, compared with $265 million, primarily reflecting seasonal changes in working capital.
- Cash and cash equivalents at June 27, 2026, totaled $997 million, compared with $713 million.
- Total debt was $1.2 billion, consistent with the prior year period.
- Gross leverage ended the third quarter at 2.8x, compared with 2.9x in the prior year and below the target range of 3.0 to 3.5x.
- Net leverage was 0.5x.
Analysis
Central reported Q3 fiscal 2026 net sales of $882 million, down 8% from $961 million, while organic net sales increased 2% to $862 million from $842 million. The filing attributes the difference to the exit of the pet distribution business at the beginning of the quarter. Reported earnings declined, with GAAP net income of $90 million versus $95 million and GAAP diluted EPS of $1.45 per diluted share versus $1.52. Non-GAAP net income was $96 million versus $98 million, and non-GAAP diluted EPS was $1.54 per diluted share versus $1.56.
Margins improved across the consolidated business despite lower reported sales. Gross margin expanded to 35.9% from 34.6%, GAAP operating margin rose to 14.3% from 14.1%, non-GAAP operating margin rose to 15.4% from 14.5%, and adjusted EBITDA margin increased to 18.3% from 17.3%. Management cited favorable margins due primarily to the pet distribution exit. Adjusted EBITDA declined to $162 million from $167 million, but the margin result indicates that the lower reported sales base carried a more favorable profitability profile.
Pet net sales were $400 million, down 19% from $493 million, reflecting the distribution-business exit, while Pet organic net sales were $380 million and increased 2%. Pet GAAP operating income declined to $67 million from $76 million, but GAAP operating margin increased to 16.7% from 15.5%. Pet non-GAAP operating margin expanded to 19.0% from 15.8%, and adjusted EBITDA margin increased to 21.4% from 17.9%. Garden was the reported-growth segment, with sales of $482 million, up 3% from $468 million, driven primarily by Wild Bird, Fertilizer and Controls, and Grass Seeds. Garden GAAP operating income rose to $90 million from $83 million.
Liquidity strengthened during the period. Cash provided by operations was $327 million compared with $265 million, primarily reflecting seasonal changes in working capital. Cash and cash equivalents were $997 million at June 27, 2026, compared with $713 million, while total debt was $1.2 billion and gross leverage was 2.8x, below the stated target range of 3.0 to 3.5x. The company had $128 million remaining for future stock repurchases. Following quarter-end, Central agreed to acquire an 80% interest in TRIXIE for €340 million in cash at closing plus up to €60 million in additional earn-out payments.
Central raised fiscal 2026 non-GAAP diluted EPS guidance from $2.70 or better to $2.85 or better. The revised outlook is based on year-to-date results and improved visibility into the balance of the year, and management cited continued margin discipline, growth investment, and portfolio optimization. The outlook includes assumptions for a competitive and promotional retail environment, a value-oriented consumer, existing tariffs, and inflation in select commodities. It excludes potential effects from acquisitions, divestitures, restructuring activities, and further tariff refunds.
Management, verbatim
Third quarter results showed continued strength across the business with improvements in both organic sales and margins versus last year, reflecting sharp execution and favorable margins due primarily to the exit of the pet distribution business earlier this year. Following the quarter, we entered into a definitive agreement to acquire a majority interest in TRIXIE, the leading European pet supplies and pet snacks company, a significant step in expanding our presence in Europe.
Niko Lahanas, CEO of Central Garden & Pet
As we enter the final phase of the garden season, and given the strength we've seen across the business, we're raising our fiscal year outlook.
Niko Lahanas, CEO of Central Garden & Pet
Not in the filing
stated, not guessed- Prior-quarter comparisons for all reported metrics.
- Free cash flow.
- Dividend declaration or payment.
- Actual stock repurchases during Q3 fiscal 2026.
- Revenue, gross-margin, operating-expense, and tax-rate guidance for fiscal 2026.
- Exact prior-year amount for other income.
- Exact prior-year amount for net interest expense.
- Exact prior-year amount for total debt.
- Tax expense and tax rate.
- Share count.
- Detailed cash-flow items beyond cash provided by operations.
- Previous-release outlook required to assess reported results versus prior guidance.
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
This is an SEC Form 8-K with Exhibit 99.1 covering Central Garden & Pet’s fiscal 2026 third-quarter results and updated full-year non-GAAP EPS guidance, plus a post-quarter definitive agreement to acquire a majority stake in TRIXIE.
Ticker impact
Central Garden & Pet reported Q3 FY2026 results and raised full-year non-GAAP diluted EPS guidance to $2.85 or better, plus disclosed an 80% TRIXIE acquisition agreement.
Likely positive bias for CENT on guidance-up and acquisition clarity, with follow-through dependent on investor focus on pet distribution exit and integration assumptions.
The filing includes specific Q3 EPS and margin figures, a quantified guidance increase, and a definitive post-quarter acquisition agreement with stated consideration and expected close timing.
Market effects
Pet supplies and garden consumer staples read-through via margin discipline, portfolio optimization, and European consolidation narrative.
Europe expansion via TRIXIE deal may shift sentiment toward European pet specialty consolidation and cross-border consumer supply chains.
Tariff and commodity inflation assumptions embedded in guidance highlight macro sensitivity for consumer discretionary-adjacent staples.
Counterpoint
Organic pet segment growth is offset by reported pet segment net sales decline tied to the distribution exit, so investors may discount the headline improvement.
Key entities
- public_companyCENT
Central Garden & Pet Company, reporting Q3 FY2026 results, raising FY non-GAAP EPS guidance, and signing an 80% TRIXIE acquisition agreement.
- private_or_foreign_companyTRIXIE Heimtierbedarf GmbH & Co. KG
Leading European pet supplies and pet snacks company; Central agreed to acquire an 80% interest for €340 million cash plus up to €60 million earn-out.
- personNiko Lahanas
CEO of Central, quoted regarding margin improvements and the TRIXIE acquisition rationale.
- personBrad Smith
CFO of Central, hosting the conference call to discuss results and business update.
